Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PBE vs RYOIX overlap: 37% of top holdings shared

Bottom line

How much do PBE and RYOIX overlap?

37% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 41.4% of PBE's assets and 28.1% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.

RYOIX holds far more positions (74 vs 33), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PBERYOIX
Weight overlap (top 25)37%
Shared holdings10
Weight in shared holdings41.4%28.1%
Total positions3374
Expense ratio0.59%1.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings PBE and RYOIX have in common

Holding% of PBE% of RYOIXOverlap
Regeneron Pharmaceuticals, Inc.5.47%2.93%2.93%
Amgen Inc.5.22%5.05%5.05%
Vertex Pharmaceuticals Inc.4.99%4.32%4.32%
Biogen Inc.4.79%2.13%2.13%
Gilead Sciences, Inc.4.43%4.49%4.43%
United Therapeutics Corp.4.08%1.72%1.72%
Illumina, Inc.3.51%1.94%1.94%
Alnylam Pharmaceuticals, Inc.3.17%2.36%2.36%
Incyte Corp.3.06%1.62%1.62%
Neurocrine Biosciences, Inc.2.66%1.52%1.52%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PBE

  1. Invesco Private Prime Fund — 12.89%
  2. CareDx, Inc. — 5.04%
  3. Invesco Private Government Fund — 4.97%
  4. Royalty Pharma PLC — 4.94%
  5. Bio-Techne Corp. — 3.73%
  6. Protagonist Therapeutics, Inc. — 3.40%
  7. Vericel Corp. — 3.27%
  8. Repligen Corp. — 3.04%
  9. Acadia Pharmaceuticals Inc. — 3.02%
  10. Halozyme Therapeutics, Inc. — 2.98%
  11. Qiagen N.V. — 2.89%
  12. BioMarin Pharmaceutical Inc. — 2.82%
  13. Exelixis, Inc. — 2.64%
  14. BioCryst Pharmaceuticals, Inc. — 2.63%
  15. Veracyte, Inc. — 2.60%

Only in RYOIX

  1. Abbvie Inc — 8.17%
  2. Revolution Medicines Inc — 2.48%
  3. Beone Medicines Ltd — 2.17%
  4. Moderna Inc — 2.15%
  5. Natera Inc — 2.12%
  6. Royalty Pharma Plc — 2.01%
  7. Insmed Inc — 1.79%
  8. Guardant Health Inc — 1.72%
  9. Roivant Sciences Ltd — 1.66%
  10. Viatris Inc — 1.55%
  11. Argenx Se — 1.48%
  12. Jazz Pharmaceuticals Plc — 1.42%
  13. Bridgebio Pharma Inc — 1.38%
  14. Ionis Pharmaceuticals Inc — 1.35%
  15. Cytokinetics Inc — 1.35%

Asset mix

Asset typePBERYOIX
Stocks100.1%99.6%
Cash & short-term funds17.9%0.6%
Repurchase agreements—0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryPBERYOIX
US108.6%85.8%
GB4.9%3.2%
CH—3.3%
NL2.9%1.5%
IE—2.7%
BM—1.7%
KY1.6%0.5%
DE—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PBE and RYOIX overlap?
About 37% by weight. 10 securities appear in both funds' top 25 holdings; they make up 41.4% of PBE's assets and 28.1% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PBE and RYOIX have in common?
The largest shared holdings are Amgen Inc., Gilead Sciences, Inc., Vertex Pharmaceuticals Inc., Regeneron Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc..
Should I own both PBE and RYOIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PBE or RYOIX?
RYOIX is broader, with 74 positions versus 33 for PBE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.